Mizuho Initiates Coverage On Minimed Group with Outperform Rating, Announces Price Target of $21

Mizuho analyst Anthony Petrone initiates coverage on Minimed Group (NASDAQ:MMED) with a Outperform rating and announces Price Target of $21.